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Background: Oropharyngeal colostrum (OC) application strategies have been shown to be
feasible and safe for very low birth weight (VLBW) infants. Evidence to support the nutritional
and clinical advantages of OC care remains somewhat theoretical. The objectives of this study
were to a) confirm the feasibility and safety of OC application in preterm infants and b) deter-
mine if OC application is associated with improved nutritional and clinical outcomes from birth
to discharge. We hypothesized that OC application in the first few days would promote sus-
tained breast milk feedings through discharge.
Methods: An observational longitudinal study was conducted in 133 VLBW infants during 2013
e14, after an OC protocol was adopted. Maternal and infant characteristics, infant vital signs
during administration, nutritional outcomes, and common neonatal morbidities were assessed
and compared to 85 age- and weight-matched VLBW infants from a retrospective control
cohort from 2012, prior to the implementation of the OC protocol.
Results: There were no adverse events or changes in vital signs during the application of OC.
VLBW infants who received OC continued to receive the majority of their enteral feeds from
human breast milk at six 6 of age and through discharge (p < 0.01). There was no difference
in maternal characteristics known to affect breast milk production, and rates of common
neonatal morbidities were statistically similar between groups.
Abbreviations: BPD, bronchopulmonary dysplasia; DOL, day of life; BM, breast milk; BPD, bronchopulmonary dysplasia; IVH, interventricular
hemorrhage; NEC, necrotizing enterocolitis; NPO, nil per os; NICU, neonatal intensive care until; OC, oropharyngeal colostrum; PICC,
peripherally inserted central catheter; ROP, retinopathy of prematurity; SIP, spontaneous perforations; TPN, total parenteral nutrition;
VAP, ventilator associated pneumonia; VLBW, very low birth weight.
* Corresponding author. Department of Pediatrics, Morristown Medical Center, 100 Madison Avenue, Morristown, NJ 07960, USA.
E-mail addresses: ruth.snyder@atlantichealth.org (R. Snyder), Aimee.herdt@atlantichealth.org (A. Herdt), Nancy.mejias-cepeda@
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Conclusion: OC application for VLBW infants is safe and practical in a neonatal intensive care
unit setting and is associated with increased rates of breast milk feeding.
Copyright ª 2017, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
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1. Introduction
Human breast milk is the best source of nutrition for
newborn babies, prompting recommendations that infants
be exclusively breastfed for the first six months of life.1 In
addition to the nutritional benefits of breast milk, it also
contains important digestive enzymes, immunological and
anti-inflammatory factors, antioxidants, growth factors and
hormones that all contribute to improved neonatal host
immune defense and overall long-term health.2e4 Breastfed
infants are often less susceptible to infection and metabolic
disorders (i.e., obesity and/or type II diabetes), and may
have improved neurodevelopmental and cardiovascular
outcomes in later life.5e9 Nonetheless, breastfeeding rates
remain suboptimal, most notably among premature infants,
who may most greatly benefit from the protective effects
of human breast milk.10,11 Sustained breast milk feedings
has been shown to decrease the incidence and severity of
several common neonatal complications of prematurity,
such as necrotizing enterocolitis (NEC), sepsis, retinopathy
of prematurity (ROP), bronchopulmonary dysplasia
(BPD), feeding intolerance and neurodevelopmental
impairment.12e15 Despite the many advantages associated
with providing maternal breast milk d to premature infants,
several barriers remain that disrupt the relationship and
often overshadow the opportunities to promote and provide
human breast milk feedings.16
In the immediate postnatal period for very low birth
weight (VLWB) infants, enteral feedings are not always
possible and oral feedings are not practical because of
developmental immaturity.17 To bridge the gap to the
introduction of enteral breast milk, the practice of early
application of oropharyngeal colostrum (OC) was pro-
posed as a protective strategy.18 This application of OC in
this early neonatal period is feasible and safe for VLBW
infants that are not yet able to receive enteral feeds.18e24
Immunoprotective factors are more highly concentrated
in the colostrum of mothers who deliver preterm infants
and may offer many of the same protective and immu-
nological benefits as those observed from human breast
milk.21e28 However, there is limited evidence to support
the biological and clinical advantages of OC care.21,22 We
hypothesized that the benefits of OC are not limited to
the direct protection against serious clinical outcomes,
but in fact, mothers who provide OC to VLBW infants in
the first few days will continue to provide breast milk for
a longer period of time. Therefore, we performed an
observational longitudinal study in VLBW infants to
confirm the feasibility of OC application in VLBW infants,
and determine the short- and long-term effect of OC




We prospectively monitored and longitudinally followed
133 VLBW infants (<1500 g) from birth through discharge in
the neonatal intensive care unit at Goryeb Children’s Hos-
pital, Morristown, NJ, between January 2013 and December
2014. In January 2013, an OC protocol was adopted for
VLBW infants whose mothers provided their own
colostrum.18e20,29 (Appendix). A separate retrospective
control cohort of VLBW infants from 2012 (n Z 85),
immediately prior to initiation of the OC protocol (pre-OC),
was included in the study and compared to the infants in
the OC protocol. Maternal support and education on the
benefits of using breast milk did not change over the course
of the study and was the same for both the OC and pre-OC
cohorts. The OC protocol was not part of a new feeding
protocol. In our unit, a feeding protocol for VLBW infants
was established in 2010, and therefore was the same for
both the cohort enrolled in the OC protocol and the pre-OC
cohort in this study. Infants with suspected congenital
anomalies, congenital heart disease (except hemodynami-
cally insignificant ventricular or atrial septal defects),
congenital gastrointestinal or renal anomalies, or history of
maternal substance abuse were excluded from the study.
The same exclusion criteria applied for the experimental
and control groups. Infants that did not receive OC because
of maternal illness or unavailability of mother’s first milk
were also excluded. The institutional review board at
Atlantic Health System approved the study. Written
informed consent was obtained from the parents or
guardians of all participants.
2.2. Oropharyngeal colostrum (OC) protocol
The OC protocol was stratified by birth weight, so that
infants weighing less than 1000 g (n Z 51) received 0.1 ml
of colostrum via syringe or swab to each buccal mucosa
(0.05 ml/side), and infants weighing between 1000 and
1500 g (n Z 82) received 0.2 ml colostrum to each buccal
mucosa (0.1 ml/side), every 2e4 h in addition to standard
patient care for five days, (anticipated number of doses
ranged from 30 to 60). Vital signs were monitored during
OC application, and the procedure was immediately
stopped if the infant had a desaturation episode with ox-
ygen saturation less than 85%, bradycardia (heart rate,
HR < 100/min), tachycardia (HR > 200/min), tachypnea
(respiratory rate, RR > 80/min), or apnea. The mothers
were given verbal education on the proposed benefits of
providing OC to their infants. Maternal characteristics that
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influence the production of breast milk were documented
at the time of delivery (Table 1) and infant demographics
were recorded upon neonatal intensive care unit (NICU)
admission (Table 2).
2.3. Data collection
The following nutritional outcome measures were assessed;
time of first OC dose (hours), total number of doses, day of
life (DOL) first feeds, DOL infants regained birth weight,
DOL infants reached 120 ml/kg/day feeds, type of first
feeds (breast milk or preterm formula), and the majority of
feeds (>50% breast milk, unfortified or fortified; formula
only; or a combination of breast milk and formula) at 1
week of age, 6 weeks of age, and at discharge. The mor-
bidities monitored were central line days, NEC (medical and
surgical,Bells stage 2), spontaneous intestinal perforation
(SIP, pneumoperitoneum with pneumatosis from a single
intestinal perforation), suspected sepsis, ventilator associ-
ated pneumonia (VAP, culture positive tracheal aspirate
specimen), ROP (stage 2 or higher), bronchopulmonary
dysplasia (BPD, National Institutes of Health [NIH] workshop
definition), interventricular hemorrhage (IVH Grade III/IV),
and death.
2.4. Statistical analysis
All data are expressed as median values (interquartile
ranges) or percentages. Continuous variableswere tested for
normality using the KolmogoroveSmirnov test and a histo-
gram illustration of the data. Comparisons were adjusted for
gestational age at birth. Unpaired t-test or Mann Whitney U
test, where appropriate, was used to compare the two
groups: (a) pre-OC protocol (n Z 85); and OC protocol
(n Z 133). We controlled for the maternal characteristics
and infant characteristics (Tables 1 and 2) in the analysis. All
of the maternal and infant characteristics, as well as the
infant nutritional and clinical outcomes, were collected by
one observer (A.H.) blinded to the clinical status of the VLBW
infants. We assigned p < 0.05 as statistically significant
(Stata 13.0; StataCorp, College Station, TX).
3. Results
There were 96 VLBW infants admitted to our NICU in 2012,
of which 85 infants (89%) met eligibility criteria for this
study. After the initiation of our OC protocol, there were
189 VLBW infants admitted to our NICU (2013e2014), of
which 156 infants (83%) were eligible to receive OC. Thirty-
three of these eligible infants did not receive OC due to
maternal illness or decision, or inability to provide breast
milk. Therefore, 218 infants were included in this study, 85
in the pre-OC protocol and 133 in the OC-protocol (Fig. 1).
Among infants that received OC, the median time for OC
initiation was 24 h after birth (interquartile range [IQR]: 12
to 43), and these infants received a median number of 27
OC doses (IQR: 20 to 33). There were no adverse changes in
vital signs during the application of OC in any of the infants.
Specifically, there were no episodes of hypotension, apnea,
bradycardia, or desaturations associated with the applica-
tion of OC. Maternal characteristics were similar between
the OC and non-OC groups (Table 1). Infant demographics
are summarized in Table 2.
In our study, the day of life (DOL) that feeds were initi-
ated, DOL infants regained their birth weight, and the DOL
they reached 120ml/kg/day feedswere unchanged between
Table 1 Maternal characteristics for pre-oropharyngeal







Age (years) 33 (29,35) 32 (28,35) 0.82
BMI (kg/m2) 29 (26,34) 29 (26,34) 0.68
Gravida 2 (1,3) 2 (1,3) 0.12
Chorioamnionitis
(yes)
1 (1%) 4 (3%) 0.40
Pre-eclampsia 16 (19%) 20 (15%) 0.60
Premature rupture
of membranes
4 (5%) 10 (8%) 0.45
Smoking (yes) 4 (5%) 10 (8%) 0.45
Alcohol (yes) 0 0 NA
Mode of delivery
(C-section)




6 (7%) 8 (6%) 0.45
Gestational
diabetes mellitus
5 (6%) 7 (5%) 0.65
Maternal
hypothyroidism
5 (6%) 8 (6%) 0.42
Data are presented as median values.









28 (26,30) 28 (26,30) 0.69
Birth weight
(grams)
1060 (817,1345) 1025 (805,1275) 0.50
Birth weight strata, n (%)
500e749 16 (19%) 27 (20%) 0.45
750e999 20 (24%) 38 (29%) 0.56
1000e1249 22 (26%) 32 (24%) 0.73
1249e1500 27 (31%) 36 (27%) 0.42
Gender
(female)
47 (55%) 61 (46%) 0.12
Race 0.78
Caucasian 55 (65%) 93 (70%)
Black 11 (13%) 10 (8%)
Asian 13 (15%) 19 (14%)
Other 6 (7%) 19 (14%)
Data are presented as median (interquartile ranges) or number
(percentage).
NA, not applicable.
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the groups, irrespective of gestational age at birth. There
was no difference in the DOL for first feeds or majority type
of feeds during the first week of life. However, there was a
significant association between OC application and receiving
breast milk as themajority of enteral feeds at 6 weeks of age
(p Z 0.03) and through discharge (p Z 0.007). These out-
comes remained consistent when adjusted for maternal
characteristics known to affect breast milk production,
gestational age at birth, time to OC initiation, and total
number of doses (Table 3). There were no statistical im-
provements in the incidence of common neonatal morbid-
ities among infants that received OC care. The occurrence of
NEC, SIP, sepsis, VAP, ROP, IVH, or BPD was all statistically
similar between groups (Table 4).
4. Discussion
Toour knowledge, this is one of the largest evaluations on the
impact of early OC application on clinical and nutritional
outcomes in VLBW infants from birth through discharge. Our
study results are in-linewith a growing collection of evidence
that suggests OC care is safe and feasible in VLBW
infants.18e20 In this study we also considered maternal
characteristics that may affect breast milk production: most
notably, we were able to show that the initiation of an OC
protocol at our center is associated with the increased rate
of breast milk feeding through discharge.
4.1. Feasibility and safety
The safety of OC for VLBW infants has been broadly
explored by Rodriguez et al.18 and others.18e20,22,27,30 While
the strategies for OC care among these studies have
differed slightly, they have consistently shown that the
application of OC does not lead to adverse clinical events
(agitation, aspiration, bradycardia, or tachycardia) or
disrupt standard of care. Similarly, the VLBW infants that
received OC in our study did so without incident (of these
65 were extremely low birth weight). We found that
mothers were generally willing to provide colostrum for OC
application, which allowed 81% of eligible VLBW infants to
receive OC.
In more recent studies, the feasibility of OC application
for critically ill VLBW infants has been explored; specifically
by assessing the use of OC in ventilated VLBW infants, and
by attempting to administer OC at earlier times and for
more sustained periods.20 In previous studies, most found it
impractical to administer colostrum during the first 24 h
after birth, and on average, neonates were older than 2
days upon initiation of OC.18e20,22,27,29,30 In our study, we
also made every attempt to initiate OC as early as possible
and found that the median time for OC initiation was 24 h
after birth (IQR: 12 to 43). Despite this success, the vari-
ability we experienced in OC initiation, and instances of
late OC initiation, nearly always correlated to the time milk
expression was initiated in new mothers. At our center, we
estimate that the average time to start milk expression in
mothers of NICU infants is about 6e8 h after delivery; a
timeframe that generally allows for OC application within
the first 24 h after birth.
Additional determinants of OC feasibility are the per-
centage of planned doses administered and frequency. In
separate studies, Montgomery et al. and Lee et al. found
that 75e80% of the planned swabbings were actually given
Fig. 1 Study Subject Flow Diagram: * Infants with suspected congenital anomalies of the airway, congenital heart disease (except
hemodynamically insignificant ventricular or atrial septal defects), congenital gastrointestinal or renal anomalies, or history of
maternal substance abuse were excluded from the study. ** For 33 out of the 166 eligible infants that did not receive OC, we noted
that maternal illness, or maternal unwillingness prevented colostrum from being collected.
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as proposed every 3 h.27,30 In an ongoing randomized con-
trol trial to determine the efficacy of OC for VLBW infants,
completed treatment is defined as having received at least
70% of planned doses.31 In our study, the median number of
doses was 27 (IQR: 20 to 33). Although this falls short of our
goal for OC application every 2 h for 5 days (goal: 60 doses),
it is >70% of planned doses for OC application every 4 h for
5 days (goal of 30 doses). Overall, this reflects a strategy of
minimal stimulation employed by the nurses, who preferred
not to handle the infants more than every 3e4 h while
simultaneously checking vitals.32 Additionally, planned OC
doses may have been missed if fresh or refrigerated
colostrum was not available, if OC application was dis-
continued at the time enteral feeds were started, or based
on the acuity of NICU infants and staffing demands. In our
analysis, infants who received OC were still more likely to
be discharged home on breast milk, irrespective of the total
number of received doses in the first 5 days of life.
4.2. Nutritional outcomes
Recently, investigators have described improvements to
several nutritional outcomes for VLBW infants because of
OC application or a standardized feeding protocol that in-
cludes OC care.19,29 Specifically, reports have shown that
these infants more often receive breast milk for their first
feedings, may begin enteral feeds earlier, and may reach
full feeds (100e150 ml/kg/day) more quickly.19 Additional
studies suggest that OC application may also reduce the
amount of time an infant requires total parenteral nutrition
(TPN) and decrease the number of peripherally inserted
central catheter (PICC)-line days.29 Unlike these previous
studies, we found no difference in the time to initiate
enteral feeds or the time to reach full feeds between in-
fants that did and did not receive OC. In part, our result
likely reflects the recent change in NICU culture to start
trophic feeds as early as possible.33 In a recent study,
Romano-Keeler et al.17 also observed no difference in the
time to initiate enteral feeds (median age of 2 days) be-
tween groups, further validating this cultural shift. Similar
to Lee et al.27 we also found no difference in the time it
took for infants to regain their birth weight and no differ-
ence in time to reach full enteral feeds.
In this study, there was no association between OC
application and the first feed or majority of enteral feeds in
the first week of life. These results may be explained by the
fact that maternal support and education on the benefits of
breast feeding, timely lactation, and milk expression were
consistent throughout the study period for both the pre-OC
and OC cohorts, and the feeding protocol did not change
upon the implementation of an OC protocol. On the other
hand, there was an association between OC application and
receiving breast milk as the majority of enteral feeds at 6
weeks of age, and through discharge. While the biological
explanation of this association is unclear, we hypothesize















2 (1,3) 1 (1,2) 0.22
Day regained
birth weight
10 (8,13) 9 (7,12) 0.85
Day reach
120 ml/kg/day
12 (9,19) 15 (12,23) 0.29
First feeding? 0.56
Breast milk 50 (59%) 73 (55%)





Breast milk 70 (83%) 120 (90%)
Formula 13 (15%) 7 (5%)




Breast milk 47 (55%) 89 (67%)
Formula 26 (31%) 24 (18%)
Discharge feedingb 0.007
Breast milk 27 (32%) 70 (53%)
Formula 46 (54%) 47 (35%)
Mixture 10 (12%) 9 (7%)
Data are presented as median (interquartile ranges) or number
(percentage); NA, not applicable.
a At six weeks, 12 (14%) and 20 (15%) were already discharged
from the pre-OC and OC protocol groups, respectively. At six
weeks of age, infants received either fortified breast milk or
formula.
b At discharge, infants received unfortified breast milk, for-
tified breast milk, formula, or a mixture of formula and breast
milk.







PICC line days 11 (7,19) 10 (6,19) 0.30
Medical NEC 6 (7%) 9 (7%) 0.88
Abdominal surgery
SIP 5 (6%) 4 (3%) 0.27
Surgical NEC 4 (5%) 6 (5%) 0.85
Suspected sepsis 3 (4%) 10 (8%) 0.32
VAP (yes) 0 3 (2%) 0.19
ROP (stage 2 or higher) 11 (13%) 12 (9%) 0.51
IVH (Grade III or IV) 4 (5%) 7 (5%) 0.66
BPD 18 (21%) 20 (15%) 0.41
Data are presented as median (interquartile ranges) or number
(percentage).
PICC, peripherally inserted central catheter.
SIP, spontaneous intestinal perforation.
NEC, necrotizing enterocolitis (Bell’s stage 2).
VAP, ventilator associated pneumonia.
ROP, retinopathy of prematurity.
IVH, intraventricular hemorrhage.
BPD, bronchopulmonary dysplasia.
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that even with the same maternal education and support
for the two cohorts, OC application may have provided an
additional psychological boost to mothers by allowing them
to participate in their infant’s first oral experience. We
speculate that in this way, OC care can strengthen the
mothereinfant dyad interaction, even at a time of minimal
handling and stimulation, which can lead to positive long-
term nutritional benefits.
In our center, infants <1500 g receive bovine fortifiers
when they reach 100 ml/kg/day feeds and they remain on
fortification through discharge. We did not assess whether
OC care and/or fortification alters important metabolic
factors, such as the level of alkaline phosphatase. We also
did not consider the use of donor human milk as a source of
OC; future work is needed to explore its role and benefits in
this capacity. Despite these limitations, our preliminary
observations on the nutritional benefits of OC are important
to the field.
4.3. Secondary outcome measures
Theoretical evidence suggests that colostrum may be an
ideal “first immune stimulator” for premature infants21,22;
and indeed premature human colostrum has higher con-
centrations of proteins, cytokines, and secretory immuno-
globins compared with term colostrum or mature
milk.26,27,34 Several authors have recently described the
theoretical mechanisms by which the immunologic factors
in OC may stimulate and protect the immature neonatal
immune system. Recently, a set of small published studies
have shown that OC application may lead to a reduction in
clinical morbidities in VLBW infants, such as NEC, sepsis,
VAP, and SIP,12,19,29,35 whereas other studies have been
inconclusive with respect to some of these clinical out-
comes.19,27 Although we did not find a reduction in the
incidence of common neonatal morbidities in these infants
in this study, it was underpowered to detect significant
differences in most of the common morbidities of prema-
turity because of the lack of robust literature linking them
to OC care. This limitation restricts our ability to make
conclusive statements about whether OC application alters
a premature infant’s risk for these morbidities.
4.4. Limitations of this study
This study involved a comparison of two cohorts of VLBW
infants, one studied before and one studied after imple-
mentation of a clinical protocol for OC application in the
NICU. Such nonconcurrent comparisons did not allow for
evaluation of cytokine, chemokine, and antioxidant de-
fense system profiles in both periods, thus limiting our
ability to retrieve information regarding these factors. An
adequately powered, randomized controlled trial to eval-
uate the influence of OC administration on these common
clinical outcomes and immunological markers is needed to
provide more robust evidence for the efficacy of OC.27,31
5. Conclusion
In this study, we confirmed that OC application is safe and
practical in VLBW infants and found that implementation of
an OC protocol is associated with increased breast feeding
rates at 6 weeks, and through discharge. Given the unde-
niable benefits of breast milk for VLBW infants, OC may
serve as a catalyst for increasing breastfeeding rates and
duration among premature infants.
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